Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agree with you post SB. UK is key, but one market may do better than another.
Serioulsy this stock is in big time trouble if UK is bad
I have doubts about Femprox and RayVa (but will be happy with the launch of any item that can sell even if marginal)
I am dissappointed there is no NeXact \ OTC products (translate that that into "No one buys in the technolgoy")
I hope they review that again
Private label sales of OTC topical meds are huge ( I work for a retailer that sell them)
Maybe, but the stock has more going for it now but the Pascoe PPS Plunge continues. I will give him this, the last quarter's SGA expense was lower than I thought it would be.
Dr D had APRI at $6. Pascoe will never see that price
This cancer thing with Viagra is interesting and disturbing ( in a way) If the research is reliable, the FDA has to pull the plug. That could take forever.
However will doctors take the research to heart and suspend scubscription.
Too early for any actions on anyone's part
Only sales will drive PPS. APRI will not move on news it appears. If world wide sales are expected to be 300M some day, what would be a reasonable number for UK (1 qtr) $5M to $10M
Do they have to announce ATM's imediatley whenever there is a decent report? Couldn't they wait a few days, ride the crest, toss in a few fluff PR's then announce when teh stock is higher.
ATM automatic when a small Bio company announces earnings that at least meet or exceed expectations. You know they will be selling some soon.
Kind of means taht sales will not be adeuate to fund R&D expenditures and the phony bonuses that the qtrly report wlll produce.
The 3rd and 4th qtr reports are really what will drive or drop the PPS
Worse than scary
Can't argue that point.
Another launch would help the mood
So after reading your exchanges, I am disappointed to see the comments of the posters that have tried it. Basically the drug should work imedately.
No reason for a long time poster like Cartonet to post anything less than the truth. The other poster seemed sincere in his commnets.
I like feedback so hopefully somoeone we trust will have postive comments
Everyone has been quick to dismiss the posters who say Vitaros is not working the problem is has anyone posted anything really psotive.
I thought this would equal to viagra to close without the side effect
Was the UK deal mostly milestones and no royalties or cash and royalites? I seem to remeber it was different than most of DR D and Pascoes deals
I think it is at the "IF" stage "IF" it works and "IF" it sells.
three years ago this looked like a lay up.
The market clearly doubts it. It looks like no one will take a large stake and trust me Hedgies take large syakes in small companies Look at Baupost investmetns in AVEO and IDEN
Ther is no buzz at all
Yup and the launch would also help or even a new market I have been waiting so long it doesn't matter much to me anymore
Yeah but at this rate the PPS will be red today. The market is yawning at this news. It has been said here many times only terrific sales will get this to run
Launch day Man this has been a long haul. Do you think Vitaros can get 20% of the UK within a year. 30% would go a long way to mmeting fixed costs
Hopefully your faith is not misplaced in Pascoe. Still haven't seen him do anything that Damaj wouldn't or couldn't have done. However I wll give him credit for aggresisively downsizing to preserve assets
Still think the managemetn team is in over its head
Easy to pick or Dr D. But you mustn't have been here for Viv Lu. He saved this company and his deals were probably as good or better than anything Pascoe put together. I am not defending his reach in cancer meds, but if you make any money in this stock his ground work was key.
On anothr subject, the upcoming UK launch is key but I really think the second partner launch will be the one that casuse the PPS to rise. By the time a second launch is under way we should see some results from UK, so it will sweeten the pot so to speak
Not much buzz in the trading world. Real low volume
Maybe the quesion \ answer will be in the CC
The UK PR just mentioned shipments in preparation of a launch I really do not think they ordered product for retail sales. IMO
I think (but cannot be certain) that it is demo product for doctors etc.
Would takeda announce commericaliztion
BOD members are part of a private club They take care of each other. The Comp packages are the key and barriers to entry are huge. Bring in in a shareholder to voice the minority opinion HA
Haven't read all the posts but I am guessing that these shipments are or will be samples for doctors vs actual retail items.
Also a poster (forgot who ) listed the Vitaros drug info obtained from drugs.com a few months ago and it had Takeada UK. Will one of these sheet exist for each Euro country.
With the Biotech stocks plunging lately and the Dow's flucuations, maybe it is good the launch has not been announced.
YMB c'mon
The Board is bored or better yet anixious
What new info or DD is out there. There are new products. No defintiely launch dates. (only internal debate)
Femprox has been debated ad nausean
NexAct was dead until recenlty
Yes, ther have been a few deal and some national approvals
There have been disputes, diagreemetns and bickering but it is reasonalby civil compared to YMB
It enough for me but the market is unfaxed or skeptical as always
I really do not expect a launch for a few months. I said this back in Janaury thinking we would not see much action until mid year.
I would think there would be some signs of a launch For instance an upfront campaing (not adv but infomration), distribution of literature to prescribers etc., then shipments, and then hopefully sales.
I would think there would be some buzz coming out of Europe if anything was happening.
Then again next week would be better
Canada Laucnch? I do not hold out hope of a near term CN launch
Sometiems I think it will only happen with the Room Temp unit.
I would be happy with just knowing what the plan is to resolve or determine shelf life issues.. Are they perfroming studies, test etc.
When there are issues, disclosure is better than silence
Can't assign income. They would recognize the full amount
I they were awarded $1.8 it has to be booked
The only way they will ever get a big upofront payment they launch, sell well and then go into a new terroty
NexACT is back in 2014?? I hope that is exaplained \ clarified in the CC
How do we define launch??
Is a Launch shipments of actual product in the hands of a partner?
Product on the shelf a drug store or actual sales.
To me it makes a difference.
I thought there would be more tell tale signs when a new drug program was beginning. Like literature in doctor’s offices, commitment to retailers etc
Good day yesterday
APRI Jumps follow up today??
Lots of good banter on the board
Pats sign Revis
Briuns paste Habs
So how about a summer launch or two reght before football seson starts
I am starting to think we would be lucky to get just one (1 country) launch in 2014. I would be surpirsed in there were more than 2 but would not be surprised if there were none.
However I also would like a verbal confriamtion that product is shipped. It would make a nice PR. Any PR is great
With today's filing, is the whole French sales team mess behind us.
It seemed ilke a good idea at first, but that is why smaller companies use partners or brokers
Agree with Value, APRI can't launch, only partners can . I think they will not launch unitl they have the infrastructure in place. Logistics is the concern I have. Longs have waited a while. A few more months will not kill us.
Agree with DG, APRI geting back US rights is far fetched. It would only happen if Vitaros is a bust.
Not sure why, but the best way to drop the APRI PPS is to post positive PR. Seems to happen a lot.
An updated letter to shareholders \ report would be a lot better than an SA article
It has been a while since an SA article has been written about APRI. About time
SA articles have taken a hit lately however due a a paid pumper and insider selling. As for mid year launch, that is what I have thought all along.
There just aren't any signs of a 1st qtr launch. Buying op maybe but we have been saying that for years.
Company guidiance??? would help
I mentioned 3rd qtr because (hope I am wrong) becasue shouldn't there be a marketing campaign prior to the launch Ie literature for doctors etc.
I mean are they going launch Vitaros without a marketing effort
SB APRI management is playing the same game with pay and bonuses all publicly held compoanies do. The BOD members are part of the same club so it just goes on and on. It is disgusting but a fact
They set goals the are easy to achieve so they can't help but achieve their goals.
I can't be certain but I also beleive that DR D could have struck the same deals as Pascoe maybe better ones. Pascoe deals don't seem lights out.
Also if the French sales team was still in force could France be the first to launch Maybe
Pascoe downsized to preserve resources. Was it the right move? Time will tell.
Does APRI mgmt deserve large bonuses. Well they met the goals approved by the board, so good for them
It is too bad minority shareholders can't get equal time. But would anyone disagree that if a launch doesn't occur by 3rd qtr 2014, the team should be scrapped
As I recently said, I don't think we will see a launch this qtr - maybe in Q2 There would be more of a buzz out there if a launch was happening by March IMO
As for CN, I don;t know but I have the bad feeling it won't happen until the Room Temp item is avaialbe IMO again.
Hope I am wrong on both counts.
Spain and Russia is cool but again how long until the real launch
Russia??? that should be an interesting market